Bayer (FRA:BAYN) PT Set at €86.00 by Berenberg Bank

Share on StockTwits

Bayer (FRA:BAYN) has been assigned a €86.00 ($100.00) price target by analysts at Berenberg Bank in a report released on Tuesday, Borsen Zeitung reports. The firm currently has a “buy” rating on the healthcare company’s stock. Berenberg Bank’s target price would indicate a potential upside of 14.82% from the company’s previous close.

A number of other equities research analysts also recently commented on BAYN. Goldman Sachs Group set a €77.00 ($89.53) target price on Bayer and gave the stock a “buy” rating in a research report on Monday, November 18th. UBS Group set a €110.00 ($127.91) target price on Bayer and gave the stock a “buy” rating in a research report on Tuesday, November 19th. DZ Bank reiterated a “neutral” rating on shares of Bayer in a research report on Thursday, October 31st. Barclays set a €85.00 ($98.84) target price on Bayer and gave the stock a “buy” rating in a research report on Friday, October 25th. Finally, Nord/LB set a €64.00 ($74.42) target price on Bayer and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have assigned a buy rating to the company. Bayer currently has a consensus rating of “Hold” and a consensus price target of €79.94 ($92.95).

FRA:BAYN opened at €74.90 ($87.09) on Tuesday. Bayer has a 12 month low of €91.58 ($106.49) and a 12 month high of €123.82 ($143.98). The business’s 50-day moving average is €71.61 and its 200 day moving average is €66.01.

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Read More: What are no-load funds?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Louisiana State Employees Retirement System Trims Position in Lindsay Co.
Louisiana State Employees Retirement System Trims Position in Lindsay Co.
Louisiana State Employees Retirement System Has $358,000 Holdings in ABIOMED, Inc.
Louisiana State Employees Retirement System Has $358,000 Holdings in ABIOMED, Inc.
IFP Advisors Inc Sells 513 Shares of Takeda Pharmaceutical Co Ltd
IFP Advisors Inc Sells 513 Shares of Takeda Pharmaceutical Co Ltd
IFP Advisors Inc Purchases 117 Shares of Hasbro, Inc.
IFP Advisors Inc Purchases 117 Shares of Hasbro, Inc.
Amarin Co. plc  Shares Sold by IFP Advisors Inc
Amarin Co. plc Shares Sold by IFP Advisors Inc
IFP Advisors Inc Has $46,000 Stock Holdings in First Solar, Inc.
IFP Advisors Inc Has $46,000 Stock Holdings in First Solar, Inc.


 
© 2006-2020 Zolmax.